Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.767B
Cash
422.7M
Avg Qtr Burn
-38.54M
Short % of Float
8.18%
Insider Ownership
0.37%
Institutional Own.
81.24%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Obicetrapib Details Heterozygous familial hypercholesterolemia, Atherosclerotic cardiovascular disease | Phase 3 Data readout | |
Obicetrapib + ezetimibe Details Dyslipidemia, Hypercholesterolemia | Phase 3 Update | |
Obicetrapib Details Alzheimer's disease | Phase 2a Update |